Bunge Purchases Assets of MCN BioProducts; Terms Not Disclosed

Bunge Limited

today announced it has purchased substantially all of the assets, including the patent portfolio, of MCN BioProducts Inc., a privately-held Canadian technology company. Financial terms of the transaction were not disclosed. Assets purchased include intellectual property related to the conversion of canola and rapeseed meals into nutritionally dense protein concentrates that can replace both fish meal and vegetable protein concentrates in animal diets, including aquaculture.